Hypoxia-Inducible Factor-1α Regulates High Phosphate-Induced Vascular Calcification via Type III Sodium-Dependent Phosphate Cotransporter 1
Open Access
- 26 March 2024
- journal article
- research article
- Published by Wiley in Cardiology Research and Practice
- Vol. 2024, 1-9
Abstract
Vascular calcification (VC) has a high incidence in patients with chronic kidney disease, which is a worldwide public health problem and presents a heavy burden to society. Hypoxia-inducible factor (HIF)-1α, the active subunit of HIF-1, has been reported to play a vital role in high phosphate-induced VC. However, the underlying mechanism is still undetermined, and effective treatment is unavailable. In the present study, human aortic smooth muscle cells (HASMCs) were cultured under normal or high phosphate media conditions. HIF-1α small interfering RNA and overexpression plasmids were employed to regulate HIF-1α expression. Phosphonoformic acid was employed to restrain the function of type III sodium-dependent phosphate cotransporter 1 (Pit-1). The expression levels of HIF-1α, Pit-1, runt-related transcription factor 2 (Runx2), and smooth muscle 22 alpha (SM22α) were evaluated, and the calcium contents were also examined. Cell growth was assessed using an MTT assay. High phosphate stimulation caused an upregulation in HIF-1α and Pit-1 expression levels and induced calcium depositions in HASMCs. Upregulation of Runx2 expression accompanied by downregulation of SM22α expression was observed in the high phosphate group. Following the suppression of HIF-1α expression, there was a concomitant attenuation in Pit-1 expression, calcium deposition, the alteration of phenotypic transition marker genes, and vice versa. The most serious calcium deposition was noted in HASMCs cultured under high phosphate conditions which were pretreated with a HIF-1α overexpression plasmid. However, when the biological functions of Pit-1 were restrained, the putative serious calcium deposition was not formed even in HASMCs transfected with a HIF-1α overexpression plasmid. The findings confirmed that HIF-1α regulated Pit-1 expression and exerted its pro-calcifying effect through Pit-1, which identified HIF-1α and Pit-1 as therapeutic targets for high phosphate-induced VC.Keywords
Funding Information
- Natural Science Foundation of Hubei Province (2021CFB445, 82260150, 2021YFZD026)
- National Natural Science Foundation of China (2021CFB445, 82260150, 2021YFZD026)
- Science and Technology Key Project of Jingmen City (2021CFB445, 82260150, 2021YFZD026)
This publication has 25 references indexed in Scilit:
- Mitochondria Homeostasis and Vascular Medial CalcificationCalcified Tissue International, 2021
- Iron Sucrose: A Double-Edged Sword in High Phosphate Media-Induced Vascular CalcificationCalcified Tissue International, 2021
- Sustainable Development Goals relevant to kidney health: an update on progressNature Reviews Nephrology, 2020
- Targeting Vascular Calcification in Chronic Kidney DiseaseJACC: Basic To Translational Science, 2020
- Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemiaCellular and Molecular Life Sciences, 2019
- Advanced glycation end products accelerate calcification in VSMCs through HIF-1α/PDK4 activation and suppress glucose metabolismScientific Reports, 2018
- Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcificationKidney International, 2016
- Evolving importance of kidney disease: from subspecialty to global health burdenThe Lancet, 2013
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001